Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with type 2 diabetes and are 19 years of age or older at the time of joining.
- You have been taking metformin combined with either a DPP-4i or SGLT-2i diabetes medication (both taken by mouth) continuously for at least 8 weeks before joining.
- Your HbA1c (a blood test measuring average blood sugar levels over time) is between 7.0% and below 10.0%, based on a test taken within 4 weeks of joining.
- You are willing to give written consent to take part after being fully informed about the study.
Who may not be able to join:
- You have type 1 diabetes or a form of diabetes caused by another medical condition.
- You have been taking three or more different diabetes medications (taken by mouth) at the same time within the 8 weeks before joining.
- You need to use insulin, GLP-1 medications, or similar treatments during the study period.
- You have severe kidney disease or are currently on kidney dialysis (hemodialysis).
- You have or have had a serious diabetes complication called diabetic ketoacidosis.
- You are currently pregnant or breastfeeding.
- You have a known allergy or sensitivity to any of the study medications or their ingredients.
- Any other medical reason that the study doctor believes makes participation unsuitable for you (confirm with trial site).
- You have any other condition that the study medication's official guidelines say it should not be used for (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 82-2-6373-0773
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of Incidence of Adverse events in Triple Combination Therapy Including Metformin with SGLT-2i, DPP-4i, or TZD Class Drugs.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.